AAAAAA

   
Results: 1-17 |
Results: 17

Authors: BUSMANIS IA BEATY AE BASSER RL
Citation: Ia. Busmanis et al., ISOLATED PLEURAL EFFUSION WITH HEMATOPOIETIC-CELLS OF MIXED LINEAGE IN A PATIENT RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY, Diagnostic cytopathology, 18(3), 1998, pp. 204-207

Authors: CLARKE K BASSER RL MAHER D MORGAN DJ CEBON J FOX RM HILL JS ALT C BARTLET J GELDARD H KAYE AH GREEN MD
Citation: K. Clarke et al., PHASE-I AND PHARMACOKINETIC STUDY OF KRN8602 ALONE AND WITH FILGRASTIM IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2181-2187

Authors: BASSER RL TO LB BEGLEY CG MAHER D JUTTNER C CEBON J MANSFIELD R OLVER I DUGGAN G SZER J COLLINS J SCHWARTZ B MARTY J MENCHACA D SHERIDAN WP FOX RM GREEN MD
Citation: Rl. Basser et al., RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR, Journal of clinical oncology, 16(5), 1998, pp. 1899-1908

Authors: MORGAN DJ HILL JS CLARKE K STYLLI SS PARK SJ CEBON J BASSER RL KAYE AH GELDARD H MAHER DW GREEN MD
Citation: Dj. Morgan et al., EFFECT OF FILGRASTIM ON THE PHARMACOKINETICS OF MX2 HYDROCHLORIDE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 423-426

Authors: THOMAS DM BASSER RL SEYMOUR JF GREEN MD SZER J FOX RM GRIGG AP
Citation: Dm. Thomas et al., PROGRESS IN MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN AUSTRALIA SINCE 1980 - A SINGLE INSTITUTION RETROSPECTIVE STUDY, Australian and New Zealand Journal of Medicine, 28(2), 1998, pp. 190-196

Authors: MORGAN DJ HILL JS CLARKE K STYLLI SS PARK SJ CEBON J BASSER RL KAYE AH GELDARD H MAHER DW GREEN MD
Citation: Dj. Morgan et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MX2 HYDROCHLORIDE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, Cancer chemotherapy and pharmacology, 40(3), 1997, pp. 202-208

Authors: RASKO JEJ BASSER RL BOYD J MANSFIELD R OMALLEY CJ HUSSEIN S BERNDT MC CLARKE K OBYRNE J SHERIDAN WP GRIGG AP BEGLEY CG
Citation: Jej. Rasko et al., MULTILINEAGE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN HUMANS FOLLOWING ADMINISTRATION OF PEG-RHUMGDF, British Journal of Haematology, 97(4), 1997, pp. 871-880

Authors: BASSER RL RASKO JEJ CLARKE K CEBON J GREEN MD GRIGG AP ZALCBERG J COHEN B OBYRNE J MENCHACA DM FOX RM BEGLEY CG
Citation: Rl. Basser et al., RANDOMIZED, BLINDED, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR WITH FILGRASTIM AFTER DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER, Blood, 89(9), 1997, pp. 3118-3128

Authors: BASSER RL RASKO JEJ CLARKE K CEBON J GREEN MD HUSSEIN S ALT C MENCHACA D TOMITA D MARTY J FOX RM BEGLEY CG
Citation: Rl. Basser et al., THROMBOPOIETIC EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN PATIENTS WITH ADVANCED CANCER, Lancet, 348(9037), 1996, pp. 1279-1281

Authors: ABRAHAM R BASSER RL GREEN MD
Citation: R. Abraham et al., A RISK-BENEFIT ASSESSMENT OF ANTHRACYCLINE ANTIBIOTICS IN ANTINEOPLASTIC THERAPY, Drug safety, 15(6), 1996, pp. 406-429

Authors: OMALLEY CJ RASKO JEJ BASSER RL MCGRATH KM CEBON J GRIGG AP HOPKINS W COHEN B OBYRNE J GREEN MD FOX RM BERNDT MC BEGLEY CG
Citation: Cj. Omalley et al., ADMINISTRATION OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR TO HUMANS STIMULATES THE PRODUCTION OF FUNCTIONALPLATELETS THAT SHOW NO EVIDENCE OF IN-VIVO ACTIVATION, Blood, 88(9), 1996, pp. 3288-3298

Authors: BASSER RL TO LB BEGLEY CG JUTTNER CA MAHER DW SZER J CEBON J COLLINS JP RUSSELL I OLVER I GILL PG FOX RM SHERIDAN WP GREEN MD
Citation: Rl. Basser et al., ADJUVANT TREATMENT OF HIGH-RISK BREAST-CANCER USING MULTICYCLE HIGH-DOSE CHEMOTHERAPY AND FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Clinical cancer research, 1(7), 1995, pp. 715-721

Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954

Authors: BASSER RL
Citation: Rl. Basser, DOSE-INTENSIVE CHEMOTHERAPY IN BREAST-CANCER - THE NEED FOR APPROPRIATE MEASURES OF OUTCOME, Annals of oncology, 6(7), 1995, pp. 633-635

Authors: ROBERTS AW BEGLEY CG GRIGG AP BASSER RL
Citation: Aw. Roberts et al., DO STEADY-STATE PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS PREDICT THE YIELD OF PBPC MOBILIZED BY FILGRASTIM ALONE, Blood, 86(6), 1995, pp. 2451-2451

Authors: BASSER RL SOBOL MM DUGGAN G CEBON J ROSENTHAL MA MIHALY G GREEN MD
Citation: Rl. Basser et al., COMPARATIVE-STUDY OF THE PHARMACOKINETICS AND TOXICITY OF HIGH-DOSE EPIRUBICIN WITH OR WITHOUT DEXRAZOXANE IN PATIENTS WITH ADVANCED MALIGNANCY, Journal of clinical oncology, 12(8), 1994, pp. 1659-1666

Authors: BASSER RL SMITH JG WOROTNIUK V GUINEY MJ
Citation: Rl. Basser et al., CONSERVATIVE MANAGEMENT OF SQUAMOUS-CELL CARCINOMA OF THE ANAL-CANAL, Australian and New Zealand journal of surgery, 64(11), 1994, pp. 754-758
Risultati: 1-17 |